• Galapagos announces positive CHMP opinion for Jyseleca® (filgotinib) for the treatment of adults with moderately to severely active ulcerative colitis

    16 hours ago

  • Mithra announces Estelle® approval in Russia

    1 day ago

  • IBA and SCK CEN join forces to enable production of Actinium-225

    Wednesday September 15th 2021

  • Precirix and IFE sign clinical trial manufacturing agreement

    Monday September 13th 2021

  • Biotalys officially opens new headquarters and research facilities in Ghent

    Thursday September 9th 2021

  • Flamingo Therapeutics expands alliance with Ionis Pharmaceuticals to develop RNA-targeted therapies for oncology

    Thursday September 9th 2021

  • Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases

    Thursday September 9th 2021

  • ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV infected pigs

    Thursday September 9th 2021

  • Your news here?

  • Ardena acquires Idifarma from Suanfarma, adding spray drying technology and high potency capabilities

    Monday September 6th 2021

  • Novalis Biotech Acceleration invests in San Francisco-based Modality.AI - technology that ‘self-drives’ neurological and psychiatric assessments

    Friday September 3rd 2021

  • Quality by Design zet nieuwe stap in groeiverhaal: Qarad vervoegt QbD Group

    Thursday September 2nd 2021


Strategic Partners